These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Sleep apnea is a manifestation of the metabolic syndrome. Vgontzas AN, Bixler EO, Chrousos GP. Sleep Med Rev; 2005 Jun; 9(3):211-24. PubMed ID: 15893251 [Abstract] [Full Text] [Related]
8. Increase in Body Mass Index Decreases Duration of Apneas and Hypopneas in Obstructive Sleep Apnea. Leppänen T, Kulkas A, Mervaala E, Töyräs J. Respir Care; 2019 Jan; 64(1):77-84. PubMed ID: 30578359 [Abstract] [Full Text] [Related]
16. The effect of sibutramine-assisted weight loss in men with obstructive sleep apnoea. Yee BJ, Phillips CL, Banerjee D, Caterson I, Hedner JA, Grunstein RR. Int J Obes (Lond); 2007 Jan; 31(1):161-8. PubMed ID: 16652122 [Abstract] [Full Text] [Related]
17. [Heart failure and sleep apnea]. Dursunoğlu D, Dursunoğlu N. Turk Kardiyol Dern Ars; 2010 Mar; 38(2):135-43. PubMed ID: 20473019 [Abstract] [Full Text] [Related]
18. Prevalence of comorbidities in patients with obstructive sleep apnea syndrome, overlap syndrome and obesity hypoventilation syndrome. Lacedonia D, Carpagnano GE, Patricelli G, Carone M, Gallo C, Caccavo I, Sabato R, Depalo A, Aliani M, Capozzolo A, Foschino Barbaro MP. Clin Respir J; 2018 May; 12(5):1905-1911. PubMed ID: 29227046 [Abstract] [Full Text] [Related]
19. Sibutramine versus continuous positive airway pressure in obese obstructive sleep apnoea patients. Ferland A, Poirier P, Sériès F. Eur Respir J; 2009 Sep; 34(3):694-701. PubMed ID: 19357147 [Abstract] [Full Text] [Related]
20. [Sleep apnea syndromes and cardiovascular disease]. Bounhoure JP, Galinier M, Didier A, Leophonte P. Bull Acad Natl Med; 2005 Mar; 189(3):445-59; discussion 460-4. PubMed ID: 16149210 [Abstract] [Full Text] [Related] Page: [Next] [New Search]